PURPOSE: To investigate the stability of KSL, an antimicrobial decapeptide, and its analogues, in human saliva and simulated gastric fluid for delivery in the oral cavity. MATERIALS AND METHODS: The degradation products of KSL in human saliva and simulated gastric fluid were separated by reversed-phase HPLC and their structures were identified by electrospray ionization-mass spectrometry. Analogues of KSL were synthesized by solid-phase synthesis procedure. Their enzymatic stabilities and antimicrobial activities were studied. RESULTS: KSL was degraded by the peptide bond cleavages at Lys(6)-Val(7) in the human saliva and Phe(5)-Lys(6) in simulated gastric fluids. Three analogues of KSL were synthesized; the Lys(6) residue was either methylated (KSL-M), or replaced with Trp (KSL-W), or the d-form of Lys (KSL-D). The KSL analogues were much more stable than the native KSL, with the rank order of stability being KSL-D > KSL-W > KSL-M > KSL in human saliva. However, in simulated gastric fluid, while KSL-D was still stable, KSL-W was significantly degraded. In addition, KSL-D significantly lost the antimicrobial activity, whereas KSL-W completely preserved the activity against several oral bacteria. In a chewing gum formulation, KSL-W showed a more sustained release profile as compared with the native KSL. CONCLUSION: This study suggests that KSL-W could be used as an antiplaque agent in a chewing gum formulation.
PURPOSE: To investigate the stability of KSL, an antimicrobial decapeptide, and its analogues, in human saliva and simulated gastric fluid for delivery in the oral cavity. MATERIALS AND METHODS: The degradation products of KSL in human saliva and simulated gastric fluid were separated by reversed-phase HPLC and their structures were identified by electrospray ionization-mass spectrometry. Analogues of KSL were synthesized by solid-phase synthesis procedure. Their enzymatic stabilities and antimicrobial activities were studied. RESULTS:KSL was degraded by the peptide bond cleavages at Lys(6)-Val(7) in the human saliva and Phe(5)-Lys(6) in simulated gastric fluids. Three analogues of KSL were synthesized; the Lys(6) residue was either methylated (KSL-M), or replaced with Trp (KSL-W), or the d-form of Lys (KSL-D). The KSL analogues were much more stable than the native KSL, with the rank order of stability being KSL-D > KSL-W > KSL-M > KSL in human saliva. However, in simulated gastric fluid, while KSL-D was still stable, KSL-W was significantly degraded. In addition, KSL-D significantly lost the antimicrobial activity, whereas KSL-W completely preserved the activity against several oral bacteria. In a chewing gum formulation, KSL-W showed a more sustained release profile as compared with the native KSL. CONCLUSION: This study suggests that KSL-W could be used as an antiplaque agent in a chewing gum formulation.
Authors: Dong Hee Na; Yu Seok Youn; Sang Deuk Lee; Mi-Won Son; Won-Bae Kim; Patrick P DeLuca; Kang Choon Lee Journal: J Control Release Date: 2003-10-30 Impact factor: 9.776
Authors: Dong Hee Na; Yu Seok Youn; Eun Ji Park; Jeong Min Lee; Ock Ryun Cho; Kang Ro Lee; Sang Deuk Lee; Sun Dong Yoo; Patrick P DeLuca; Kang Choon Lee Journal: J Pharm Sci Date: 2004-02 Impact factor: 3.534
Authors: J L Reubsaet; J H Beijnen; A Bult; R J van Maanen; J A Marchal; W J Underberg Journal: J Pharm Biomed Anal Date: 1998-09-01 Impact factor: 3.935
Authors: S Y Hong; J E Oh; M Kwon; M J Choi; J H Lee; B L Lee; H M Moon; K H Lee Journal: Antimicrob Agents Chemother Date: 1998-10 Impact factor: 5.191
Authors: Simon Theberge; Abdelhabib Semlali; Abdullah Alamri; Kai P Leung; Mahmoud Rouabhia Journal: BMC Microbiol Date: 2013-11-07 Impact factor: 3.605